Crossmark

Evaluating comparative effectiveness of pembrolizumab-based therapy versus chemotherapy in treatment of gastric carcinoma: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s10238-025-01610-5

Published Online: 2025-03-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mansoor, Haleema https://orcid.org/0009-0000-2111-1509
Gohar, Maheen https://orcid.org/0009-0005-3546-8281
Attaria, Asma https://orcid.org/0009-0001-6495-9080
Karim, Faiza Fatima https://orcid.org/0009-0001-7883-7519
Naeem, Umaimah https://orcid.org/0009-0004-2317-6866
Khan, Mohsin https://orcid.org/0009-0006-2353-0276
Iqbal, Javed https://orcid.org/0000-0003-2627-685X
Funding

Funding for this research was provided by:

Hamad Medical Corporation
License Information

Text and Data Mining valid from 2025-03-28

Version of Record valid from 2025-03-28
More Information

Article History

Received: 3 January 2025

Accepted: 24 February 2025

First Online: 28 March 2025

Declarations

:

: The authors declare no competing interests.